A Case Report on Use of Anesthetic Conserving Device in a Patient with Bullous Cystic Lung Disease

Résumé fourni par la source

lead to improved outcomes in mechanically ventilated patients, including reduced risk of lung injury, decreased need for sedation and analgesia, and improved management of bronchospasm.AnaConDa (Anesthetic Conserving Device), manufactured by Sedana Medical, is a medical device designed to reduce the amount of anesthetic gases that are released into the environment during IntroductIonMechanical ventilation is a lifesaving intervention used in critically ill patients with respiratory failure.However, it is not without risks, as it can cause harm to the lungs, increase the need for sedatives and analgesics, and prolong the time patients spend on mechanical ventilation.One way to mitigate these risks is by using an anesthetic conserving device (ACD).Effective sedation and analgesia are of utmost importance in intensive care unit (ICU) to reduce pain, anxiety, and delirium during mechanical ventilation.1,2 An ACD is a device that is placed between the patient and the ventilator circuit, which captures exhaled anesthetic gases and recycles them back to the patient during the next inhalation.This allows for a reduction in the number of anesthetic agents required, thereby reducing the risk of adverse effects associated with their use.In addition to reducing the number of anesthetic agents needed, ACDs have also been shown to benefit patients with bronchospasm.Bronchospasm is a condition characterized by constriction of the airways, which can lead to difficulty in breathing.ACDs have been found to reduce the incidence and severity of bronchospasm in mechanically ventilated patients, likely due to the decreased need for anesthetic agents, which can irritate the airways.Overall, the use of ACDs can 1,

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.